Cannabics Pharmaceuticals Inc buy melinda
Start price
21.02.17
/
50%
€5.33
Target price
21.02.17
€6.00
Performance (%)
14.11%
End price
21.02.17
€6.08
Summary
This prediction ended on 21.02.17 with a price of €6.08. The BUY prediction by melinda finished with a performance of 14.11%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cannabics Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by melinda for this prediction
In the thread Cannabics Pharmaceuticals Inc diskutieren
ein anderer Cannabis
Itamar Borochov CEO Cannabics Pharmaceuticals, sagte : "Wir sind das erste Unternehmen weltweit eine Anti-Tumor - Diagnose Cannabinoide Patienten personalisierte Krebs zu bieten. Wir freuen uns , Pioniere auf dem Link Cannabis und personalisierte Krebstherapien zu sein. "
(Zielkurs erreicht)
Stopped prediction by melinda for Cannabics Pharmaceuticals Inc
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.10
02.01.18
02.01.18
€4.00
03.07.18
03.07.18
-63.24%
03.07.18
03.07.18
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.84
24.08.17
24.08.17
€2.00
02.01.18
02.01.18
151.31%
02.01.18
02.01.18
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€4.25
22.02.17
22.02.17
€7.00
22.08.17
22.08.17
-80.02%
22.08.17
22.08.17
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.99
21.02.17
21.02.17
€7.00
22.02.17
22.02.17
16.86%
22.02.17
22.02.17
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.80
17.02.17
17.02.17
€4.00
17.02.17
17.02.17
5.26%
17.02.17
17.02.17